What the Inflation Reduction Act means for PBMs

The sweeping law President Joe Biden enacted Tuesday offers relief to some presciption drug users, but the pharmacy benefit managers that play a key role in how much patients pay for medicines will mostly carry on as usual.

The Inflation Reduction Act limits drug companies and pharmacy benefit managers from charging rates on select Medicare drugs that allow them to pocket high rebates. But it mostly spares the pharmaceutical middlemen, who…